Human CXCL7/NAP-2 Antibody, R&D Systems™

Goat Polyclonal Antibody

Supplier:  R&D Systems AF393SP

Catalog No. AF393SP

Description

CXCL7/NAP-2 Polyclonal specifically detects CXCL7/NAP-2 in Human samples. It is validated for Western Blot, Simple Western.

Specifications

• Antigen: CXCL7/NAP-2
• Classification: Polyclonal
• Conjugate: Unconjugated
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: Beta-TG, connective tissue-activating peptide III, CTAP III, CTAP3CTAP-III, CTAPIII, CXC chemokine ligand 7, C-X-C motif chemokine 7, CXCL7b-TG1, LA-PF4, LDGFTC1, Leukocyte-derived growth factor, low-affinity platelet factor IV, Macrophage-derived growth factor, MDGFTC2, NAP2, NAP-2, NAP-2-L1, neutrophil-activating peptide 2, neutrophil-activating peptide-2, PBPTHBGB, platelet basic protein, PPBP, pro-platelet basic protein (chemokine (C-X-C motif) ligand 7), SCAR10, SCYB7beta-thromboglobulin, small inducible cytokine B7, small inducible cytokine subfamily B, member 7, Small-inducible cytokine B7, TGB, TGB1B-TG1, THBGB1, thrombocidin 1, thrombocidin 2, thromboglobulin, beta-1
• Host Species: Goat
• Purification Method: Affinity Purified
• Regulatory Status: RUO
• Gene ID (Entrez): 5473
• Reconstitution: Reconstitute at 0.2 mg/mL in sterile PBS.
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

• Applications: Western Blot
• Concentration: LYOPH
• Dilution: Western Blot 0.1 ug/mL, Simple Western 10 ug/mL
• Gene Accession No.: P02775
• Gene Symbols: PPBP
• Immunogen: E. coli-derived recombinant human CXCL7/NAP-2 Ala59-Asp128 Accession # P02775
• Quantity: 25 μg
• Primary or Secondary: Primary
• Test Specificity: Detects human CXCL7/NAP-2 in direct ELISAs and Western blots. In direct ELISAs, approximately 25% cross-reactivity with recombinant mouse (rm) MIP-2 is observed, 10% cross-reactivity with recombinant human (rh) GRO alpha , rhIL-8, rhCINC-2 alpha , and rhGRO beta is observed, and 5% cross-reactivity with recombinant rat (rr) CINC-1, rrCINC-2 beta , rhGCP-2, rmKC, rhMIG, and rhGRO beta . is observed.
• Target Species: Human
• Isotype: IgG

For Research Use Only